Gene: ZNF664
Official Full Name: zinc finger protein 664provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24116 | ZNF664 Knockout cell line (HeLa) | Human | ZNF664 | 1:3~1:6 | Negative | Online Inquiry |
KO24117 | ZNF664 Knockout cell line (HCT 116) | Human | ZNF664 | 1:2~1:4 | Negative | Online Inquiry |
KO24118 | ZNF664 Knockout cell line (HEK293) | Human | ZNF664 | 1:3~1:6 | Negative | Online Inquiry |
KO24119 | ZNF664 Knockout cell line (A549) | Human | ZNF664 | 1:3~1:4 | Negative | Online Inquiry |
ZNF664 Gene Knockout Cell Lines represent a cutting-edge biological tool designed to advance research in gene function and regulation. These cell lines are engineered to have a complete disruption of the ZNF664 gene, a critical regulator involved in numerous cellular processes, including development, differentiation, and potential roles in disease mechanisms. By employing CRISPR-Cas9 gene-editing technology, these knockout cell lines allow researchers to elucidate the function of ZNF664 in various biological contexts.
The key mechanism underlying these cell lines is the precise targeted edit of the genomic DNA, leading to a loss of ZNF664 expression. This enables the investigation of the gene’s roles in cellular pathways, offering insights into its impact on cell proliferation, apoptosis, and response to stress. As ZNF664 has been implicated in various conditions, including certain cancers and developmental disorders, its study is vital for understanding the molecular basis of these diseases.
In a research or clinical setting, the ZNF664 Gene Knockout Cell Lines serve as an invaluable resource for dissecting complex biological questions and validating therapeutic targets. Their specific advantages include improved knockout specificity and reduced off-target effects, ensuring reliable experimental outcomes. Unlike conventional cell lines, these engineered models provide clearer interpretations of data regarding ZNF664-related signaling pathways.
For researchers and clinicians alike, the availability of ZNF664 Gene Knockout Cell Lines offers a unique opportunity to accelerate discoveries in gene therapy and regenerative medicine. The precision and ease of use of these cell lines significantly streamline the research process, ultimately contributing to advancements in therapeutic development.
Our company, with extensive experience in genetic engineering and product development, is committed to providing researchers with high-quality biological tools. We ensure rigorous quality control and support, empowering scientists to push the boundaries of discovery in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.